Development of Iontophoresis Device for Plasmid DNA Transfection of Hypoxia Inducible Factor-1 to Improve Wound Healing

开发用于缺氧诱导因子-1 的质粒 DNA 转染促进伤口愈合的离子电渗装置

• 批准号: 9243543
• 负责人: John W Harmon
• 金额: $ 4万
• 依托单位: CANTON BIOTECHNOLOGIES, INC.
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-05-09 至 2016-08-10
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9243543
• 关键词: Aging; Amputation; Animal Model; Animals; Anodes; Area; Biomedical Engineering; Bipolar II; Cathodes; Characteristics; Charge; Clinic; Clinical; DNA; DNA delivery; Dermis; Development; Devices; Diabetes Mellitus; Diabetic Foot Ulcer; Doctor of Philosophy; Elderly; Electrodes; Electroporation; Family suidae; Foot Ulcer; Funding; Genetic Transcription; Goals; Growth; Healed; Homing; Image; Impaired wound healing; Individual; Iontophoresis; Lead; Lower Extremity; Marketing; Messenger RNA; Modality; Modeling; Modification; Mus; Peptide Hydrolases; Peptides; Pharmaceutical Preparations; Phase; Plasmid Cloning Vector; Plasmids; Play; Production; Role; Safety; Schools; Small Business Innovation Research Grant; Staging; Stem cells; Steroids; Stromal Cell-Derived Factor 1; Time; Tissues; Transdermal substance administration; Transfection; Ulcer; United States; United States National Institutes of Health; Universities; Vascular Endothelial Growth Factors; Work; Wound Healing; absorption; aged; design; effective therapy; healing; high risk; hypoxia inducible factor 1; improved; innovation; knockout animal; novel; novel strategies; plasmid DNA; prototype; public health relevance; transcription factor; voltage; wound

DESCRIPTION (provided by applicant): Impaired wound healing is an unfortunate consequence of diabetes. It is also seen in the elderly, as well as individuals taking steroid medication. There is an urgent need for a therapy that will be safe, effective, and easy to apply to improve impaired wound healing. The situation is most urgent for individuals with diabetes, whose foot ulcers are the most frequent cause for lower extremity amputations in the United States. This project will lead initially to the marketing of a treatment modality that will promote healing of diabetic foot ulcers. It will be used for recalcitrant ulcers where healing is not progressing. It can be used for other difficult wounds as well. There is no effective treatment for such wounds at this time. Our goal for this SBIR is to develop a novel robust transfection strategy using iontophoresis. We have preliminary work showing that this can be effective. Iontophoresis is performed using a low voltage to create an electrical current in tissue. In our situation the negatively charged plasmid DNA is driven through the tissue from the anode to the cathode. For Phase 1 of this SBIR we will work with a group from Johns Hopkins University, School of Bioengineering, to optimize the electrode arrays and electrical parameters to achieve transfection suitable for improving wound healing. In Phase 2 we will assess the efficacy and safety of the approach in a porcine model. Our group has shown that the transcription factor Hypoxia Inducible Factor- 1 (HIF-1) can improve wound healing. DNA delivery of a peptide like HIF- 1 is necessary because simple application of peptide growth factors has not been effective because of poor absorption, and because the peptides are rapidly destroyed by peptidases in the dermis. The DNA plasmid delivery promotes continuous production of the peptide in the dermis to circumvent these delivery problems.

描述（由申请人提供）：伤口愈合受损是糖尿病的不幸后果。它也见于老年人，以及服用类固醇药物的人。迫切需要一种安全、有效且易于应用的疗法来改善受损的伤口愈合。糖尿病患者的情况最为紧迫，他们的足部溃疡是美国下肢截肢的最常见原因。该项目最初将导致销售一种治疗方式， 糖尿病足溃疡的愈合。它将用于愈合没有进展的顽固性溃疡。它也可以用于其他复杂的伤口。没有有效的治疗方法 此时的伤口。我们的目标是这个SBIR是开发一种新的强大的转染策略，使用离子电渗。我们的初步工作表明，这是有效的。使用低电压进行离子电渗以在组织中产生电流。在我们的情况下，带负电荷的质粒DNA被驱动通过组织从阳极到阴极。对于SBIR的第一阶段，我们将与约翰霍普金斯大学生物工程学院的一个小组合作，优化电极阵列和电参数，以实现适合于改善伤口愈合的转染。在第2阶段，我们将在猪模型中评估该方法的有效性和安全性。我们的研究小组已经证明，转录因子缺氧诱导因子-1（HIF-1）可以促进伤口愈合。像HIF- 1这样的肽的DNA递送是必要的，因为肽生长因子的简单应用由于吸收差而无效，并且因为肽在真皮中被肽酶迅速破坏。DNA质粒递送促进肽在真皮中的连续产生以规避这些递送问题。